acetic acid and Bruise studies

Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.

Research Excerpts

Excerpt	Relevance	Reference
"The purpose of this case report is to document the treatment of a patient who had traumatic myositis ossificans with acetic acid iontophoresis."	7.68	Treatment of traumatic myositis ossificans with acetic acid iontophoresis. ( Wieder, DL, 1992)
"A 2% acetic acid solution was administered via iontophoresis into the myositis ossificans, followed by 8 minutes of pulsed ultrasound at 1."	5.28	Treatment of traumatic myositis ossificans with acetic acid iontophoresis. ( Wieder, DL, 1992)
"The purpose of this case report is to document the treatment of a patient who had traumatic myositis ossificans with acetic acid iontophoresis."	3.68	Treatment of traumatic myositis ossificans with acetic acid iontophoresis. ( Wieder, DL, 1992)
"A 2% acetic acid solution was administered via iontophoresis into the myositis ossificans, followed by 8 minutes of pulsed ultrasound at 1."	1.28	Treatment of traumatic myositis ossificans with acetic acid iontophoresis. ( Wieder, DL, 1992)

Research

Studies (1)

Authors

Clinical Trials (1)

Trial Overview

Trial Outcomes

Pain Intensity (PI)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Wieder, DL	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Effectiveness of Percutaneous Microelectrolysis in the Decrease of Pain in Myofascial Trigger Points: Evaluation Through Algometry and Visual Analog Scale. Randomized Controlled Trial.[NCT03636386]		48 participants (Actual)	Interventional	2018-05-23	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Magnitude of pain expressed in millimeters (mm) referred by participants. PI was evaluated through visual analogue scale at moment of performing pressure algometry test in the sensitive point of upper trapezius muscle. PI was assessed with an analogous visual scale where the participant will mark the pain generated by the algometry on a scale of 1 to 100 millimeters. PI was valued in four occasions: PI1 pre (baseline), PI1 post, PI 2 (at day 3) and PI 3 (at day 7). (NCT03636386)
Timeframe: PIpre1 (baseline), PIpost1 (post baseline), PI2 (Day 3), PI3 (Day 7), assessed an average of 3 minutes at each session

Pain Pressure Threshold (PPT)

Intervention	mm (Mean)
	PIpre1	PIpost1	PI2	PI3	PIdiff1-1	PIdiff2-1	PIdiff3-1
Control Group (Ultrasound Therapy)	31.4	24.8	23.8	20.0	-6.6	-7.6	-11.5
Percutaneous Microelectrolysis Group (MEP)	32.1	24.6	21.6	18.1	-7.5	-10.5	-14.0

Pain Intensity expressed in kilograms per square centimeter(kg/cm2) reported by participants when performing algometry test at sensitive point of upper trapezius muscle. PPT was valued in four occasions: PPT1 pre (baseline), PPT1 post, PPT 2 (at day 3) and PPT 3 (at day 7). PPT will be evaluated through the BASELINE® pressure algometer. (NCT03636386)
Timeframe: PPTpre1 (baseline), PPTpost1 (post baseline), PPT2 (Day 3), PPT3 (Day 7), assessed an average of 30 minutes at each session

Intervention	Kg/cm2 (Mean)
	PPTpre1	PPTpost1	PPT2	PPT3	PPTdiff1-1	PPTdiff2-1	PPTdiff3-1
Control Group (Ultrasound Therapy)	1.4	1.6	1.6	1.7	0.2	0.2	0.3
Percutaneous Microelectrolysis Group (MEP)	1.4	1.6	1.7	1.9	0.2	0.4	0.5

acetic acid and Bruise